Induced hypocalcaemia controlled by a citrate clamp technique, and the intact parathyroid hormone response obtained
- PMID: 2084828
- DOI: 10.3109/00365519009104958
Induced hypocalcaemia controlled by a citrate clamp technique, and the intact parathyroid hormone response obtained
Abstract
In order to investigate (1) the possibility of controlled induction and maintenance of hypocalcaemia, and (2) the intact parathyroid hormone (PTH(1-84)) response obtained thereby, 14 healthy individuals were administered an i.v. infusion of trisodiumcitrate. The reproducibility of the method established was assessed in five of the 14 individuals. Aiming at a steady-state level of blood ionized calcium (B-Ca2+) = 1.00 mmol/l, obtained within 30 min and subsequently maintained for 90 min, the infusion was guided by frequent determinations B-Ca2+. The method established was as follows: infusion of 0.85 mmol citrate/kg body weight/h during the first 10 min, followed by 0.44 mmol citrate/kg body wt h 1.26 exp. ((actual B-Ca2(+)--target B-Ca2+)/0.02) mmol/l, until B-Ca2+ = 1.00 mmol/l. In the steady-state period the infusion rate was 0.29 mmol citrate/kg body wt. h 1.26 exp. ((actual B-Ca2(+)--target B-Ca2+)/0.02) mmol/l. The method showed reproducibility by an overall difference in B-Ca2+ measurements of -0.03 mmol/l, which did not statistically differ from zero (p less than 0.05). No severe side effects were observed during a total of 21 infusions. Intact serum parathyroid hormone concentrations (S-PTH(1-84)) obtained during induced hypocalcaemia rose to a peak within 5-10 min, and then declined to a steady-state level about three times the initial. The serum (S) PTH(1-84) response could be caused by a burst of S-PTH(1-84) from a depot source while the steady-state level may indicate a stimulated secretion from parathyroid glands. The S-PTH(1-84) response was shown to be reproducible by an overall difference in S-PTH(1-84) measurements of -0.52 pmol/l, which did not statistically differ from zero (p less than 0.10).
Similar articles
-
Normal pattern of parathyroid response to blood calcium lowering in primary hyperparathyroidism: a citrate clamp study.Clin Endocrinol (Oxf). 1992 Oct;37(4):344-8. doi: 10.1111/j.1365-2265.1992.tb02336.x. Clin Endocrinol (Oxf). 1992. PMID: 1483290
-
Cica clamp evaluation of parathyroid responsiveness in chronic hypoparathyroidism: a sequential citrate and calcium clamp study.Miner Electrolyte Metab. 1994;20(3):135-40. Miner Electrolyte Metab. 1994. PMID: 7816002
-
Progressive escape from parathyroid suppression: a common phenomenon in primary hyperparathyroidism (a calcium clamp study).Clin Endocrinol (Oxf). 1994 Mar;40(3):309-15. doi: 10.1111/j.1365-2265.1994.tb03924.x. Clin Endocrinol (Oxf). 1994. PMID: 8187293
-
Manipulation of calciumhomeostatic mechanisms in man: what are the possibilities?Acta Vet Scand Suppl. 2003;97:9-22. Acta Vet Scand Suppl. 2003. PMID: 14621391 Review.
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
Cited by
-
Derivation and comparison of formulae for the adjustment of total calcium.Front Endocrinol (Lausanne). 2023 May 12;14:1070443. doi: 10.3389/fendo.2023.1070443. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37251673 Free PMC article.
-
Dynamic assessment of the electrocardiographic QT interval during citrate infusion in healthy volunteers.Br Heart J. 1995 Jun;73(6):523-6. doi: 10.1136/hrt.73.6.523. Br Heart J. 1995. PMID: 7626350 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
